The Food and Drug Administration has issued an emergency use authorization for a rapid, single-use test to detect Ebola virus. The test is the second Ebola fingerstick test to receive an EUA, but the first to use a portable battery-operated reader. “By authorizing the first fingerstick test with a portable reader, we hope to better arm health care providers in the field to more quickly detect the virus in patients and improve patient outcomes,” said FDA Commissioner Scott Gottlieb, M.D., noting that the agency continues to collaborate with federal, international and industry partners to assist in the global response to the Ebola outbreak in the Democratic Republic of Congo.
 

Related News Articles

Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will provide $23 million for Merck to produce…
Headline
Patients receiving either of two investigational treatments for Ebola in the Democratic Republic of the Congo had a greater chance of survival than those…
Headline
One year after the Democratic Republic of the Congo declared an outbreak of Ebola, the outbreak continues in North Kivu and Ituri provinces, with 2,698 cases…
Headline
The Centers for Disease Control and Prevention is working with the U.S. Embassy in the Democratic Republic of the Congo to preposition staff in Goma to rapidly…
Headline
The World Health Organization today declared the Ebola virus disease outbreak in the Democratic Republic of the Congo a public health emergency of…
Headline
Two investigational Ebola treatments being used in the ongoing outbreak in the Democratic Republic of the Congo are effective in laboratory studies.